Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 262.93 USD 0.35% Market Closed
Market Cap: 18.4B USD
Have any thoughts about
Insulet Corp?
Write Note

Insulet Corp
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insulet Corp
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Insulet Corp
NASDAQ:PODD
Effect of Foreign Exchange Rates
$4.2m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Effect of Foreign Exchange Rates
$4m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Effect of Foreign Exchange Rates
$2m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Effect of Foreign Exchange Rates
$17m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Effect of Foreign Exchange Rates
-$53m
CAGR 3-Years
N/A
CAGR 5-Years
3%
CAGR 10-Years
2%
Intuitive Surgical Inc
NASDAQ:ISRG
Effect of Foreign Exchange Rates
-$14.5m
CAGR 3-Years
-71%
CAGR 5-Years
-45%
CAGR 10-Years
-31%
No Stocks Found

Insulet Corp
Glance View

Market Cap
18.4B USD
Industry
Health Care

Insulet Corporation is a pioneering medical device company, primarily recognized for its innovative Omnipod Insulin Management System, which revolutionizes diabetes care. Founded in 2000, Insulet has focused on developing patch pump technology that offers a seamless, tubeless insulin delivery solution for individuals with insulin-dependent diabetes. This cutting-edge product allows users to manage their insulin delivery discreetly and conveniently, enhancing their quality of life and simplifying the complex regimen of diabetes management. As the prevalence of diabetes continues to rise globally, Insulet stands at the forefront of meeting a substantial medical need, capturing a significant market share with its user-friendly technology. As an investor, understanding Insulet’s growth trajectory and market potential is essential. The company has witnessed consistent revenue growth, driven by increased adoption of its Omnipod systems, and has expanded its product portfolio to include a new generation of devices that offer even greater functionality. Insulet is also heavily investing in research and development to further innovate its offerings, positioning itself competitively in the fast-evolving diabetes care market. With strong industry partnerships and a commitment to enhancing user experience, Insulet represents not just a promising investment in healthcare technology but also a company that is fundamentally improving the lives of millions.

PODD Intrinsic Value
96.69 USD
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Insulet Corp's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
4.2m USD

Based on the financial report for Sep 30, 2024, Insulet Corp's Effect of Foreign Exchange Rates amounts to 4.2m USD.

What is Insulet Corp's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
24%

Over the last year, the Effect of Foreign Exchange Rates growth was 17%. The average annual Effect of Foreign Exchange Rates growth rates for Insulet Corp have been 24% over the past three years .

Back to Top